Nuvama lists out 4 reasons why they have rated MphasiS Buy. However they have a revised the price target lower. Find out why?

Nuvama Wealth Management announced the date to declare its third-quarter FY2024-25 results on Friday, January 24. Shares were ...

Dr Reddy's Laboratories (DRL) share price plunged 6.66 per cent to Rs 1,203.50 per share on the NSE during Friday after ...

The brokerage firm, Nuvama, has raised its target price for UltraTech Cement to Rs 11,574 per share while maintaining its ...

The fund focuses on Grade A+ office spaces across key micro-markets in India's six largest cities: Bengaluru, the National ...

The third quarter earnings season is ongoing with key companies like Coal India, Tata Steel, and Indian Oil set to announce ...

Nuvama Asset Management and Cushman & Wakefield have raised Rs 1,700 crore for their first real estate fund. They aim to ...

NCW, a JV between Nuvama Asset Management and Cushman & Wakefield, has raised Rs 1,700 crore for its Prime Offices Fund to ...

Analysts at Nuvama believe that BSE has room to grow its derivative active customer base. They also estimate that the ...

Nuvama-Cushman & Wakefield JV raises ₹1,700 crore for Prime Offices Fund targeting India's commercial real estate sector.

India's Orient Cement reported a slump in third-quarter profit on Friday due to weak prices of the key construction material amid seasonally low demand.

Nuvama and Cushman & Wakefield Management Pvt Ltd (NCW) has raised Rs 1,700 crore under its new real estate fund for making ...